Diamant Art Corp Gets Exclusive Marketing Rights In China

Lake Harmony, PA - Diamant Art Corporation (OTC BB: DIAAF) is pleased to announce today that, through its wholly owned subsidiary, Diamant Film Inc., it has secured an agreement with Diamant Plastics Corporation for the exclusive marketing and distribution rights to the Territory of People's Republic of China for Diamant stretch film, a non-PVC food wrap. Diamant Art Corporation has already secured the rights to the U.S.A., Canada, Mexico and Bahamas and now with the addition of the Territory of People's Republic of China, gives the Company exclusive marketing and distribution rights for Diamant stretch film to a population of 1.3 billion and in the North American market of $700 million industry.

Diamant stretch film is an excellent alternative to PVC film as it does not allow for the migration of harmful agents between the film and the food. Currently, stretch film food wrap products contain Poly Vinyl Chloride (PVC), a compound found to be harmful for human consumption and to the environment. In North America, legislation is being considered to limit the use of PVC products. The State of New York has already introduced restrictions on the use of PVC in the food wrap industry. The Company believes they possess the only economically viable polystyrene alternative to PVC stretch film for the North American food wrap industry.

For more information, go to http://www.cyberelease.com/diaaf103105.htm

TheNewsWire Gainers are Symmetricom Inc. (Nasdaq: SYMM), Electro-Optical Sciences, Inc. (Nasdaq: MELA), Coinstar Inc. (Nasdaq: CSTR), Radiant Systems Inc. (Nasdaq: RADS), Phazar Corp. (Nasdaq: ANTP), NovAtel Inc. (Nasdaq: NGPS), THQ Inc. (Nasdaq: THQI) and Orckit Communications Ltd. (Nasdaq: ORCT).

TheNewsWire Decliners are Giga-tronics Inc. (Nasdaq: GIGA), Universal American Financial Corp. (Nasdaq: UHCO), Tekelec (Nasdaq: TKLC), Sapient Corp. (Nasdaq: SAPE), WebEx Communications Inc. (Nasdaq: WEBX), Maxim Integrated Products Inc. (Nasdaq: MXIM), Theravance Inc. (Nasdaq: THRX) and Invitrogen Corp. (Nasdaq: IVGN).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid $595.00 for the publication and circulation of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact:
C.P. Barry
Company: CybeRelease.com
Phone: 1.888.478.7669
Source: CybeRelease.com